CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends restraints over more medicines.

The second round of negotiations cuts spending an aggregate 44% over 2024 list prices as the federal government extends restraints over more medicines.

The agency suggested cutting a dozen quality measures where health plan performance is high and beneficiaries can’t easily distinguish between offerings.

HHS reinstated all 954 workers let go last month, but firing and rehiring employees is becoming a troubling trend at the agency.

“There’s simply more at stake in these negotiations for payers and providers than there used to be,” one expert said.

The healthcare services and group purchasing organization stopped trading on Nasdaq Tuesday after more than a decade on the public markets.

A federal judge struck down the rule that would have clawed back billions of dollars in overpayments in September. Now, the HHS wants to take the case to the Fifth Circuit Court of Appeals.

Strong patient demand helped lift Mayo Clinic’s operating income by more than 250% year over year.

At the same time, more women are leaving full-time work due to caregiving demands, Guardian said.

Hospitals lambasted the final rule as inadequate, arguing the sector is facing significant financial pressures.
See how price clarity can unlock value and advance genuine patient empowerment.